| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 133, 630-638, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
TR Ulich, J del Castillo and L Souza
Department of Pathology, University of California, Irvine School of Medicine 92717.
Recombinant human granulocyte colony stimulating factor (G-CSF) injected intravenously in rats causes an initial peripheral neutropenia between 3 and 15 minutes and a subsequent neutrophilia beginning at 0.5 hours, peaking between 12 and 24 hours, and subsiding to normal between 30 and 36 hours. A striking hypersegmentation of neutrophil nuclei is observed between 30 and 48 hours. The bone marrow at 4 and 12 hours exhibits an increase in number, mitoses, size, and cytoplasmic granulation of myeloblasts and promyelocytes but a decrease in mature neutrophils, demonstrating that G-CSF acts not only as a mitogen and growth factor for early cells in the myeloid series but also as a releasing factor for mature marrow neutrophils. The bone marrow at 48 hours contains slightly increased numbers of myelocytes and metamyelocytes and large numbers of hypersegmented neutrophils. Dexamethasone and gamma-interferon inhibit the magnitude of G-CSF- induced neutrophilia, suggesting that endogenous glucocorticosteroids and gamma-interferon, both which are released along with G-CSF in vivo during endotoxemia, may play a negative feedback role in the endogenous regulation of granulopoiesis. G-CSF may act in concert with other monokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) to induce the changes in circulating numbers of leukocytes noted during endotoxemia.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Wengner, S. C. Pitchford, R. C. Furze, and S. M. Rankin The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation Blood, January 1, 2008; 111(1): 42 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Roskos, P. Lum, P. Lockbaum, G. Schwab, and B.-B. Yang Pharmacokinetic/Pharmacodynamic modeling of pegfilgrastim in healthy subjects. J. Clin. Pharmacol., July 1, 2006; 46(7): 747 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vroon, C. J. Heijnen, R. Raatgever, I. P. Touw, R. E. Ploemacher, R. T. Premont, and A. Kavelaars GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo J. Leukoc. Biol., April 1, 2004; 75(4): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kusano, S. Ebara, K. Tachibana, T. Nishimura, S. Sato, T. Kuwaki, and T. Taniyama A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor Blood, February 1, 2004; 103(3): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Adachi, M. Suzuki, T. Sugimoto, K. Yorozu, H. Takai, K. Uetsuka, H. Nakayama, and K. Doi Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity Toxicol Pathol, October 1, 2003; 31(6): 665 - 673. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Terashima, K. Amakawa, A. Matsumaru, S. van Eeden, J. C. Hogg, and K. Yamaguchi BAL Induces an Increase in Peripheral Blood Neutrophils and Cytokine Levels in Healthy Volunteers and Patients With Pneumonia Chest, June 1, 2001; 119(6): 1724 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Terashima, D. English, J. C. Hogg, and S. F. vanEeden Release of Polymorphonuclear Leukocytes From the Bone Marrow by Interleukin-8 Blood, August 1, 1998; 92(3): 1062 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Inano, S. Kameyama, S. Yasui, and A. Nagai Granulocyte Colony-stimulating Factor Induces Neutrophil Sequestration in Rabbit Lungs Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 167 - 174. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
